KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Change in Accured Expenses (2017 - 2025)

Johnson & Johnson's Change in Accured Expenses history spans 17 years, with the latest figure at -$6.8 billion for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 523.44% year-over-year to -$6.8 billion; the TTM value through Dec 2025 reached -$5.7 billion, down 451.45%, while the annual FY2025 figure was -$5.7 billion, 451.45% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$6.8 billion at Johnson & Johnson, down from $2.0 billion in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $6.0 billion in Q3 2023 and bottomed at -$6.8 billion in Q4 2025.
  • The 5-year median for Change in Accured Expenses is $889.5 million (2021), against an average of $36.4 million.
  • The largest annual shift saw Change in Accured Expenses crashed 610.03% in 2021 before it skyrocketed 437.55% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $1.3 billion in 2021, then plummeted by 311.49% to -$2.8 billion in 2022, then soared by 274.8% to $4.9 billion in 2023, then tumbled by 122.18% to -$1.1 billion in 2024, then plummeted by 523.44% to -$6.8 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Change in Accured Expenses are -$6.8 billion (Q4 2025), $2.0 billion (Q3 2025), and $1.2 billion (Q2 2025).